Literature DB >> 30804208

Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131).

Ryan A Denu1,2,3, Madilyn M Sass2,3, James M Johnson2,3, Gregory K Potts4,5,6, Alka Choudhary2,3, Joshua J Coon4,5,6, Mark E Burkard7,3.   

Abstract

The centrosome, consisting of two centrioles surrounded by a dense network of proteins, is the microtubule-organizing center of animal cells. Polo-like kinase 4 (PLK4) is a Ser/Thr protein kinase and the master regulator of centriole duplication, but it may play additional roles in centrosome function. To identify additional proteins regulated by PLK4, we generated an RPE-1 human cell line with a genetically engineered "analog-sensitive" PLK4AS, which genetically encodes chemical sensitivity to competitive inhibition via a bulky ATP analog. We used this transgenic line in an unbiased multiplex phosphoproteomic screen. Several hits were identified and validated as direct PLK4 substrates by in vitro kinase assays. Among them, we confirmed Ser-78 in centrosomal protein 131 (CEP131, also known as AZI1) as a direct substrate of PLK4. Using immunofluorescence microscopy, we observed that although PLK4-mediated phosphorylation of Ser-78 is dispensable for CEP131 localization, ciliogenesis, and centriole duplication, it is essential for maintaining the integrity of centriolar satellites. We also found that PLK4 inhibition or use of a nonphosphorylatable CEP131 variant results in dispersed centriolar satellites. Moreover, replacement of endogenous WT CEP131 with an S78D phosphomimetic variant promoted aggregation of centriolar satellites. We conclude that PLK4 phosphorylates CEP131 at Ser-78 to maintain centriolar satellite integrity.
© 2019 Denu et al.

Entities:  

Keywords:  CEP131; PLK4; cell division; centriolar satellite; centriole; centriole duplication; centrosome; chemical biology; chemical genetics; chromosome segregation; mass spectrometry (MS); microtubule; phosphoproteomics

Mesh:

Substances:

Year:  2019        PMID: 30804208      PMCID: PMC6484138          DOI: 10.1074/jbc.RA118.004867

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  GCP6 is a substrate of Plk4 and required for centriole duplication.

Authors:  Ramona Bahtz; Joerg Seidler; Marc Arnold; Uta Haselmann-Weiss; Claude Antony; Wolf D Lehmann; Ingrid Hoffmann
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

2.  Control of centriole length by CPAP and CP110.

Authors:  Thorsten I Schmidt; Julia Kleylein-Sohn; Jens Westendorf; Mikael Le Clech; Sébastien B Lavoie; York-Dieter Stierhof; Erich A Nigg
Journal:  Curr Biol       Date:  2009-05-28       Impact factor: 10.834

3.  The SCF-FBXW5 E3-ubiquitin ligase is regulated by PLK4 and targets HsSAS-6 to control centrosome duplication.

Authors:  Anja Puklowski; Yahya Homsi; Debora Keller; Martin May; Sangeeta Chauhan; Uta Kossatz; Viktor Grünwald; Stefan Kubicka; Andreas Pich; Michael P Manns; Ingrid Hoffmann; Pierre Gönczy; Nisar P Malek
Journal:  Nat Cell Biol       Date:  2011-07-03       Impact factor: 28.824

4.  Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton.

Authors:  Karineh Kazazian; Christopher Go; Hannah Wu; Olga Brashavitskaya; Roland Xu; James W Dennis; Anne-Claude Gingras; Carol J Swallow
Journal:  Cancer Res       Date:  2016-11-21       Impact factor: 12.701

5.  PLK4 phosphorylation of CP110 is required for efficient centriole assembly.

Authors:  Miseon Lee; Mi Young Seo; Jaerak Chang; Deog Su Hwang; Kunsoo Rhee
Journal:  Cell Cycle       Date:  2017-05-31       Impact factor: 4.534

6.  Functional dissection of mitotic regulators through gene targeting in human somatic cells.

Authors:  Eli Berdougo; Marie-Emilie Terret; Prasad V Jallepalli
Journal:  Methods Mol Biol       Date:  2009

7.  Plk4-induced centriole biogenesis in human cells.

Authors:  Julia Kleylein-Sohn; Jens Westendorf; Mikael Le Clech; Robert Habedanck; York-Dieter Stierhof; Erich A Nigg
Journal:  Dev Cell       Date:  2007-08       Impact factor: 12.270

8.  Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron.

Authors:  Joseph E Klebba; Daniel W Buster; Annie L Nguyen; Stephen Swatkoski; Marjan Gucek; Nasser M Rusan; Gregory C Rogers
Journal:  Curr Biol       Date:  2013-10-31       Impact factor: 10.834

9.  PCM-1, A 228-kD centrosome autoantigen with a distinct cell cycle distribution.

Authors:  R Balczon; L Bao; W E Zimmer
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

10.  Centriolar satellites: molecular characterization, ATP-dependent movement toward centrioles and possible involvement in ciliogenesis.

Authors:  A Kubo; H Sasaki; A Yuba-Kubo; S Tsukita; N Shiina
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  8 in total

1.  Doryphagy: when selective autophagy safeguards centrosome integrity.

Authors:  Valentina Cianfanelli; Francesco Cecconi
Journal:  Mol Cell Oncol       Date:  2020-02-07

Review 2.  Molecular determinants of the meiotic arrests in mammalian oocytes at different stages of maturation.

Authors:  Saffet Ozturk
Journal:  Cell Cycle       Date:  2022-01-24       Impact factor: 4.534

Review 3.  Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management.

Authors:  Debra R Garvey; Gagan Chhabra; Mary A Ndiaye; Nihal Ahmad
Journal:  Mol Cancer Ther       Date:  2021-01-05       Impact factor: 6.009

4.  Use of the Polo-like kinase 4 (PLK4) inhibitor centrinone to investigate intracellular signalling networks using SILAC-based phosphoproteomics.

Authors:  Dominic P Byrne; Christopher J Clarke; Philip J Brownridge; Anton Kalyuzhnyy; Simon Perkins; Amy Campbell; David Mason; Andrew R Jones; Patrick A Eyers; Claire E Eyers
Journal:  Biochem J       Date:  2020-07-17       Impact factor: 3.857

5.  Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2.

Authors:  Ryan M Hekman; Adam J Hume; Raghuveera Kumar Goel; Kristine M Abo; Jessie Huang; Benjamin C Blum; Rhiannon B Werder; Ellen L Suder; Indranil Paul; Sadhna Phanse; Ahmed Youssef; Konstantinos D Alysandratos; Dzmitry Padhorny; Sandeep Ojha; Alexandra Mora-Martin; Dmitry Kretov; Peter E A Ash; Mamta Verma; Jian Zhao; J J Patten; Carlos Villacorta-Martin; Dante Bolzan; Carlos Perea-Resa; Esther Bullitt; Anne Hinds; Andrew Tilston-Lunel; Xaralabos Varelas; Shaghayegh Farhangmehr; Ulrich Braunschweig; Julian H Kwan; Mark McComb; Avik Basu; Mohsan Saeed; Valentina Perissi; Eric J Burks; Matthew D Layne; John H Connor; Robert Davey; Ji-Xin Cheng; Benjamin L Wolozin; Benjamin J Blencowe; Stefan Wuchty; Shawn M Lyons; Dima Kozakov; Daniel Cifuentes; Michael Blower; Darrell N Kotton; Andrew A Wilson; Elke Mühlberger; Andrew Emili
Journal:  Mol Cell       Date:  2020-11-19       Impact factor: 17.970

6.  The SON RNA splicing factor is required for intracellular trafficking structures that promote centriole assembly and ciliogenesis.

Authors:  Alexander J Stemm-Wolf; Eileen T O'Toole; Ryan M Sheridan; Jacob T Morgan; Chad G Pearson
Journal:  Mol Biol Cell       Date:  2021-08-18       Impact factor: 4.138

7.  PLK4 is upregulated in prostate cancer and its inhibition reduces centrosome amplification and causes senescence.

Authors:  Chandra K Singh; Ryan A Denu; Minakshi Nihal; Maria Shabbir; Debra R Garvey; Wei Huang; Kenneth A Iczkowski; Nihal Ahmad
Journal:  Prostate       Date:  2022-03-25       Impact factor: 4.012

Review 8.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.